23
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Changes in 2f1-f2 Acoustic Distortion Products in Humans During Quinine-Induced Cochlear Dysfunction

Pages 600-606 | Published online: 08 Jul 2009

References

  • McFadden D, Pasanen EG. Otoacoustic emissions and quinine sulfate. J Acoust Soc Am 1994; 95: 3460–74.
  • Berninger E, Karlsson KK, Hellgren U, Eskilsson G. Magnitude changes in transient evoked otoacoustic emissions and high-level 2f1 - f2 distortion products in man during quinine administration. Scand Audiol 1995; 24: 27–32.
  • Berninger E, Karlsson KK, Alvan G. Quinine reduces the dynamic range of the human auditory system. Acta Otolaryngol 1998; 118 46–51.
  • Karlsson KK, Flock A. Quinine causes isolated outer hair cells to change length. Neurosci Lett 1990; 116: 101–5.
  • Karlsson KK, Berninger E, Alván G. The effect of quinine on psychoacoustic tuning curves, stapedius refl-exes and evoked otoacoustic emissions in healthy vol-unteers. Scand Audiol 1991; 20: 83–90.
  • Karlsson KK, Berninger E, Gustafsson LL, Alván G. Pronounced quinine-induced cochlear hearing loss. A mechanistic study in one volunteer at multiple stable plasma concentrations. J Audiol Med 1995; 4: 12–24.
  • Probst R, Lonsbury-Martin BL, Martin GK. A review of otoacoustic emissions. J Acoust Soc Am 1991; 89: 2027–67.
  • Smoorenburg GF. Audibility region of combination tones. J Acoust Soc Am 1972; 52: 603–14.
  • Lonsbury-Martin BL, Martin GK, Probst R, Coats AC. Acoustic distortion products in rabbit ear canal. I. Basic features and vulnerability. Hear Res 1987; 28: 173–89.
  • Brown AM, Kemp DT. Suppressibility of the 2f1 - f2 stimulated acoustic emissions in gerbil and man. Hear Res 1984; 13: 29–37.
  • Sininger YS, Abdala C. Otoacoustic emissions for the study of auditory function in infants and children. In: Berlin CI, editor. Otoacoustic emissions: basic science and clinical applications. San Diego, CA: Singular, 1998: 105–25.
  • Whitehead ML, Lonsbury-Martin BL, Martin GK. Evidence for two discrete sources of 2f1 - f2 distortion-product otoacoustic emission in rabbit. I. Differential dependence on stimulus parameters. J Acoust Soc Am 1992; 91: 1587–607.
  • Whitehead ML, Lonsbury-Martin BL, Martin GK. Evidence for two discrete sources of 2f1 - f2 distortion-product otoacoustic emission in rabbit. II. Differential physiological vulnerability. J Acoust Soc Am 1992; 92: 2662–82.
  • Gustafsson LL, Ebling WF, Harapat S, Osaki E, Stan-ski DR, Shafer SL. Plasma concentration clamping in the rat using a computer-controlled infusion pump. Pharm Res 1992; 9: 8007.
  • Ericsson E, Fridén M, Hellgren U, Gustafsson LL. Reversed-phase high-performance liquid chromatogra-phy determination of quinine in plasma, whole blood, urine and samples dried on filter paper. Ther Drug Monit 1993; 15: 334–7.
  • Rasmussen AN, Osterhammel PA. A new approach for recording distortion product oto-acoustic emissions. Scand Audiol 1992; 21: 219–24.
  • Popelka GR, Osterhammel PA, Nielsen LH, Ras-mussen AN. Growth of distortion product otoacoustic emissions with primary-tone level in humans. Hear Res 1993; 71: 12–22.
  • Brown AM, McDowell B, Forge A. Acoustic distortion products can be used to monitor the effects of chronic gentamicin treatment. Hear Res 1989; 42: 143–56.
  • Heitmann J, Waldmann B, Schnitzler H-U, Plinkert PK, Zenner H-P. Suppression of distortion product otoacoustic emissions (DPOAE) near 2f1 - f2 removes DP-gram fine structure-evidence for a secondary gen-erator. J Acoust Soc Am 1998; 103: 1527–31.
  • Talmadge CL, Long GR, Tubis A, Dhar S. Experimen-tal confirmation of the two-source interference model for the fine structure of distortion product otoacoustic emissions. J Acoust Soc Am 1999; 105: 275–92.
  • Shera CA, Guinan JJ. Evoked otoacoustic emissions arise by two fundamentally different mechanisms: A taxonomy for mammalian OAEs. J Acoust Soc Am 1999; 105: 782–98.
  • Paintaud G, Alván G, Berninger E, et al. The concen-tration-effect relationship of quinine-induced hearing impairment. Clin Pharmacol Ther 1994; 55: 317–23.
  • Lonsbury-Martin BL, Harris FP, Stagner BB, Hawkins MD, Martin GK. Distortion product emissions in hu-mans. I. Basic properties in normally hearing subjects. Ann Otol Rhinol Laryngol 1990; 99: 3–14.
  • Sun XM, Jung MD, Kim DO, Randolph KJ. Distor-tion product otoacoustic emission test of sensorineural hearing loss in humans: comparison of unequal- and equal-level stimuli. Ann Otol Rhinol Laryngol 1996; 105: 982–90.
  • Erminy M, Avan P, Bonfils P. Characteristics of the acoustic distortion product 2f2 - f, from the normal human ear. Acta Otolaryngol 1998; 118: 32–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.